Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iRhythm Holdings (IRTC) Gains from Sales and Divestitures (2017 - 2018)

iRhythm Holdings (IRTC) reported Gains from Sales and Divestitures of $114880.0 for Q4 2018, up 7905.57% year-over-year from $1435.0 in Q4 2017, and up 7905.57% on a QoQ basis from $1435.0 in Q4 2017.

iRhythm Holdings (IRTC) has 2 years of Gains from Sales and Divestitures data on file, last reported at $114880.0 in Q4 2018.

  • Quarterly Gains from Sales and Divestitures rose 7905.57% year-over-year to $114880.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $114880.0 (up 7905.57% YoY) and the FY2018 annual result came in at $114880.0, up 7905.57% from the prior year.
  • Gains from Sales and Divestitures climbed to $114880.0 in Q4 2018 per IRTC's latest filing, from $1435.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $114880.0 in Q4 2018 and bottomed at $1435.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 iRhythm Holdings 3.55 Bn 3.00 Bn 141.35 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 114,880.00
Dec 31, 2018 114,880.00
Dec 31, 2017 1,435.00
Dec 31, 2017 1,435.00